Search for: "Bange v. State" Results 341 - 360 of 468
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jan 2012, 8:16 pm by Lara
Kryoman v Glo-bots: prepare for courtroom hoedown over neon lights and copyrights. [read post]
19 Jun 2014, 2:09 am
The case is Case C-97/12 P Louis Vuitton Malletier v Office for Harmonisation in the Internal Market (Trade Marks and Designs), Friis Group International ApS intervening, a ruling of the Eighth Chamber of the Court of Justice of the European Union (CJEU) of 15 May. [read post]
16 Oct 2016, 7:22 pm by Smita Ghosh
 And in the New Rambler, Peter Conti Brown’s The Federal Reserve’s Big Bang and the Challenge of Institutional History covers America’s Bank: The Epic Struggle to Create the Federal Reserve by Roger Lowenstein. [read post]
19 Feb 2018, 3:22 am by Franklin C. McRoberts
Primordial Origins – Mutual Buyout Rights The LLC equitable buyout came into existence like the Big Bang, seemingly from nothing, in an unpublished decision by Justice Betty Owen Stinson in Lyons v Salamone, Decision/Order, Index No. [read post]
10 Oct 2011, 4:16 am by Marie Louise
Sheppard, Mullin, Richter & Hampton (Patents Post-Grant) District Court C D California: TP tops Despatch as court rules up is not down: Despatch Industries v TP Solar (Green Patent Blog)   US Patents – Lawsuits and strategic steps Late Allergan Reduction – “The allergans” requires all allergans not just one or more: Late Allergen Reduction v Dynarex (Chicago Intellectual Property Law Blog) Mondis – Public statements by foreign… [read post]
29 Oct 2024, 9:30 pm by Marie-Amélie George
In 2015, when he heard the Supreme Court had ruled in favor of the plaintiffs in Obergefell v. [read post]
23 Jul 2021, 11:20 am by admin
Tex. 2005) (Jack, J.)). [9] Mississippi Valley Silica Co. v. [read post]
24 Jan 2012, 11:12 am by Christopher Danzig
Yesterday, the Supreme Court handed down its opinion in United States v. [read post]
11 Oct 2011, 1:53 pm by FDABlog HPM
Conference on Rare Diseases and Orphan Products started with a bang today with the release of a landmark report announcing its findings of flexibility in FDA’s review of potential treatments for patients with rare (“orphan”) diseases. [read post]